# SXTC (China SXT Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> China SXT Pharmaceuticals, Inc. reported $1.14M in revenue and a net loss of $6.21M for the fiscal year ended March 31, 2026 (down 34.6% year over year), with a 21.9% gross margin and a -625.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/SXTC
- Markdown: https://convexityos.com/fundamentals/SXTC.md
- SEC CIK: 0001723980
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001723980&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $1.14M | -34.6% YoY |
| Operating Income | FY 2026 | -$7.12M | -625.9% margin |
| Net Income | FY 2026 | -$6.21M | -545.2% net margin |
| Diluted EPS | FY 2026 | -$9.13 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $28.18M | Total debt: $1.12M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.14M | $1.74M | $1.93M | $1.97M | $2.60M | $4.78M | $5.16M | $7.01M | $7.02M | $4.88M |
| Cost of Revenue | $889K | $1.37M | $1.37M | $1.55M | $1.35M | $1.94M | $2.46M | $2.40M | $3.62M | $2.57M |
| **Gross Profit** | $249K | $367K | $554K | $426K | $1.25M | $2.84M | $2.70M | $4.61M | $3.40M | $2.31M |
| Research & Development | -- | -- | $184K | $201K | $367K | -- | -- | -- | -- | -- |
| Selling, General & Admin | $7.37M | $3.05M | $3.07M | $6.03M | $6.44M | $5.04M | $4.04M | $2.84M | $1.77M | $710K |
| Total Operating Expenses | $7.37M | $3.05M | $3.07M | $6.03M | $6.44M | $5.04M | $4.04M | $2.84M | $1.77M | $710K |
| **Operating Income** | -$7.12M | -$2.68M | -$2.52M | -$5.61M | -$5.19M | -$2.20M | -$1.34M | $1.77M | $1.63M | $1.60M |
| **EBITDA** | -$7.05M | -$2.60M | -$2.31M | -$5.36M | -$4.87M | -$1.85M | -$1.01M | $1.95M | $1.76M | $1.70M |
| Interest Expense | $63K | $648K | $544K | $477K | $37K | $1.62M | $3.35M | $5.2K | $779 | $40K |
| Income Before Tax | -$6.21M | -$3.30M | -$3.10M | -$5.93M | -$5.41M | -$2.94M | -$10.39M | $1.79M | $1.63M | $1.58M |
| Income Tax Expense | -- | -- | -- | -- | $328K | -$193K | -$102K | $252K | $440K | $395K |
| **Net Income** | -$6.21M | -$3.30M | -$3.10M | -$5.93M | -$5.74M | -$2.75M | -$10.29M | $1.54M | $1.19M | $1.19M |
| Basic EPS | -$9.13 | -$348.17 | -$4,285.66 | -$26,542.84 | -$164,678.21 | -$114,000.00 | $993,492.54 | $2,238.81 | $1,761.19 | $1,761.19 |
| **Diluted EPS** | -$9.13 | -$348.17 | -$4,285.66 | -$26,542.84 | -$164,678.21 | -$114,000.00 | $49,671.64 | $2,238.81 | $1,761.19 | $1,761.19 |
| Basic Shares Outstanding | 679.6K | 9.5K | 723 | 224 | 35 | 24 | 10 | 689 | 670 | 670 |
| Diluted Shares Outstanding | 679.6K | 9.5K | 723 | 224 | 35 | 24 | 207 | 689 | 670 | 670 |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $28.18M | $18.10M | $12.07M | $17.37M | $77K | $13.36M | $7.29M | $9.29M | $658K |
| **Cash & Short-Term Investments** | $28.18M | $18.10M | $12.07M | $17.37M | $77K | $13.36M | $7.29M | $9.29M | $658K |
| Accounts Receivable, Net | $932K | $1.30M | $1.31M | $1.34M | $3.33M | $4.51M | $3.82M | $4.18M | $2.60M |
| Inventory | $777K | $828K | $795K | $531K | $1.02M | $860K | $893K | $1.01M | $1.27M |
| **Total Current Assets** | $34.51M | $21.30M | $14.23M | $19.52M | $22.45M | $23.23M | $19.64M | $15.59M | $6.10M |
| Property, Plant & Equipment, Net | $117K | $179K | $329K | $962K | $1.23M | $1.43M | $1.57M | $1.16M | $862K |
| Intangible Assets | $6.3K | $12K | $19K | $28K | $39K | $46K | $50K | $61K | $61K |
| **Total Non-Current Assets** | $245K | $367K | $8.89M | $10.03M | $11.09M | $11.31M | $2.07M | $1.88M | $1.56M |
| **Total Assets** | $34.75M | $21.66M | $23.13M | $29.55M | $33.55M | $34.55M | $21.70M | $17.47M | $7.66M |
| Accounts Payable | $498K | $1.16M | $1.28M | $1.38M | $1.48M | $1.46M | $1.94M | $1.69M | $2.41M |
| Short-Term Debt | $355K | $711K | $514K | $175K | $23K | $37K | $44K | $28K | -- |
| Deferred Revenue (Current) | $104K | $59K | $188K | $166K | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $789K | $1.16M | $820K | $288K | $165K | $147K |
| **Total Current Liabilities** | $4.35M | $6.01M | $8.90M | $14.50M | $17.12M | $18.58M | $12.26M | $6.32M | $4.37M |
| Long-Term Debt | $644K | $96K | $117K | $118K | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $698K | $212K | $295K | $366K | $0 | $6.3K | $37K | $42K | $0 |
| **Total Liabilities** | $5.05M | $6.22M | $9.20M | $14.86M | $17.12M | $18.59M | $12.30M | $6.36M | $4.37M |
| **Total Debt (incl. Leases)** | $1.12M | $984K | $867K | $599K | $23K | $37K | $44K | $28K | -- |
| Common Stock | $64.13M | $44.53M | $39.67M | $914K | $162K | $62K | $35K | $23K | $20K |
| Retained Earnings | -$34.22M | -$28.02M | -$24.71M | -$21.61M | -$15.69M | -$9.95M | -$7.20M | $3.08M | $1.54M |
| Accumulated Other Comp. Income | -$198K | -$1.08M | -$1.03M | -$198K | $956K | $528K | -$591K | $50K | $257K |
| **Total Stockholders' Equity** | $29.71M | $15.44M | $13.93M | $14.69M | $16.08M | $15.96M | $9.40M | $11.11M | $3.29M |
| Total Equity | $29.71M | $15.44M | $13.93M | $14.69M | $16.08M | $15.96M | $9.40M | $11.11M | $3.29M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $28.18M | $18.10M | $12.07M | $17.37M | $77K | $13.36M | $7.29M | $9.29M |
| **Cash & Short-Term Investments** | $28.18M | $18.10M | $12.07M | $17.37M | $77K | $13.36M | $7.29M | $9.29M |
| Accounts Receivable, Net | $932K | $1.30M | $1.31M | $1.34M | $3.33M | $4.51M | $3.82M | $4.18M |
| Inventory | $777K | $828K | $795K | $531K | $1.02M | $860K | $893K | $1.01M |
| **Total Current Assets** | $34.51M | $21.30M | $14.23M | $19.52M | $22.45M | $23.23M | $19.64M | $15.59M |
| Property, Plant & Equipment, Net | $117K | $179K | $329K | $962K | $1.23M | $1.43M | $1.57M | $1.16M |
| Intangible Assets | $6.3K | $12K | $19K | $28K | $39K | $46K | $50K | $61K |
| **Total Non-Current Assets** | $245K | $367K | $8.89M | $10.03M | $11.09M | $11.31M | $2.07M | $1.88M |
| **Total Assets** | $34.75M | $21.66M | $23.13M | $29.55M | $33.55M | $34.55M | $21.70M | $17.47M |
| Accounts Payable | $498K | $1.16M | $1.28M | $1.38M | $1.48M | $1.46M | $1.94M | $1.69M |
| Short-Term Debt | $355K | $711K | $514K | $175K | $23K | $37K | $44K | $28K |
| Deferred Revenue (Current) | $104K | $59K | $188K | $166K | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $789K | $1.16M | $820K | $288K | $165K |
| **Total Current Liabilities** | $4.35M | $6.01M | $8.90M | $14.50M | $17.12M | $18.58M | $12.26M | $6.32M |
| Long-Term Debt | $644K | $96K | $117K | $118K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $698K | $212K | $295K | $366K | $0 | $6.3K | $37K | $42K |
| **Total Liabilities** | $5.05M | $6.22M | $9.20M | $14.86M | $17.12M | $18.59M | $12.30M | $6.36M |
| **Total Debt (incl. Leases)** | $1.12M | $984K | $867K | $599K | $23K | $37K | $44K | $28K |
| Common Stock | $64.13M | $44.53M | $39.67M | $914K | $162K | $62K | $35K | $23K |
| Retained Earnings | -$34.22M | -$28.02M | -$24.71M | -$21.61M | -$15.69M | -$9.95M | -$7.20M | $3.08M |
| Accumulated Other Comp. Income | -$198K | -$1.08M | -$1.03M | -$198K | $956K | $528K | -$591K | $50K |
| **Total Stockholders' Equity** | $29.71M | $15.44M | $13.93M | $14.69M | $16.08M | $15.96M | $9.40M | $11.11M |
| Total Equity | $29.71M | $15.44M | $13.93M | $14.69M | $16.08M | $15.96M | $9.40M | $11.11M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.21M | -$3.30M | -$3.10M | -$5.93M | -$5.74M | -$2.75M | -$10.29M | $1.54M | $1.19M | $1.19M |
| Depreciation & Amortization | $74K | $82K | $203K | $250K | $320K | $345K | $332K | $181K | $129K | $99K |
| Stock-Based Compensation | $5.31M | -- | $352K | $555K | $2.33M | -- | -- | -- | -- | -- |
| Change in Receivables | $291K | -$257K | -$321K | $913K | $831K | -$519K | $104K | -$1.81M | $384K | -$943K |
| Change in Inventory | $36K | -$15K | -$220K | $409K | -$181K | $39K | $40K | $155K | -$274K | $384K |
| Change in Payables | -$693K | -$114K | -$29K | $9.7K | -$23K | -- | $302K | -$567K | $967K | -$1.47M |
| **Operating Cash Flow** | -$4.02M | -$2.35M | -$1.93M | -$81K | $268K | -$1.32M | $934K | $239K | $1.92M | $293K |
| Capital Expenditure | -- | -$2.0K | -$7.1K | -- | -$61K | -$78K | -$131K | -$536K | -$436K | -$179K |
| **Free Cash Flow** | -- | -$2.35M | -$1.94M | -- | $207K | -$1.39M | $803K | -$297K | $1.48M | $114K |
| **Investing Cash Flow** | -$1.25M | $64K | $26K | -$12K | -$47K | -$5.81M | -$5.50M | -$610K | -$1.05M | -$186K |
| Common Stock Issued | -- | -- | -- | -- | -$30K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $14.43M | $8.40M | -$2.62M | $2.94M | $1.60M | $12.41M | $3.02M | $9.04M | -$314K | -$51K |
| **Net Change in Cash** | $10.05M | $6.05M | -$5.29M | $1.80M | $2.21M | $6.07M | -$2.00M | $8.63M | $592K | $54K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 21.9% | 21.1% | 28.7% | 21.6% | 48.1% | 59.4% | 52.4% | 65.8% | 48.5% | 47.4% |
| **Operating Margin** | -625.9% | -154.0% | -130.4% | -284.4% | -199.4% | -46.0% | -26.0% | 25.2% | 23.3% | 32.8% |
| **Net Profit Margin** | -545.2% | -189.8% | -160.7% | -301.0% | -220.4% | -57.5% | -199.3% | 22.0% | 16.9% | 24.3% |
| Return on Equity (ROE) | -20.9% | -21.4% | -22.2% | -40.4% | -35.7% | -17.2% | -109.4% | 13.9% | 36.1% | -- |
| Return on Assets (ROA) | -17.9% | -15.2% | -13.4% | -20.1% | -17.1% | -8.0% | -47.4% | 8.8% | 15.5% | -- |
| Current Ratio | 7.93x | 3.54x | 1.60x | 1.35x | 1.31x | 1.25x | 1.60x | 2.47x | 1.40x | -- |
| Quick Ratio | 7.76x | 3.40x | 1.51x | 1.31x | 1.25x | 1.20x | 1.53x | 2.31x | 1.11x | -- |
| Debt to Equity | 0.04x | 0.06x | 0.06x | 0.04x | 0.00x | 0.00x | 0.00x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | -34.6% | -9.7% | -2.2% | -24.2% | -45.5% | -7.5% | -26.4% | -0.1% | +43.8% | -- |
| Gross Profit Growth (YoY) | -32.3% | -33.7% | +30.0% | -65.9% | -55.9% | +5.0% | -41.4% | +35.6% | +47.1% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -175.8% | +8.4% | +1.9% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -768.4% | +29.6% | +0.2% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -111.5% | +44276.0% | +27.1% | 0.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -130.1% | -- | -240.9% | +290.6% | -87.5% | +555.3% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -273.6% | -- | -120.0% | +1203.4% | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -73.8% | -16.0% | +920.5% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -291.8% | -1594.7% | -9365.1% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
